​
​

Trevi Therapeutics (TRVI) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Trevi Therapeutics Revenue Highlights

00

Trevi Therapeutics Revenue by Period

Trevi Therapeutics Revenue by Year

DateRevenueChange
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31--

Trevi Therapeutics generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Trevi Therapeutics Revenue by Quarter

DateRevenueChange
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31--

Trevi Therapeutics generated - in revenue during Q2 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Trevi Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
CHRSCoherus BioSciences--
SPROSpero Therapeutics--
FHTXFoghorn Therapeutics--
SQZSQZ Bio--
SEERSeer--
BOLTBolt Biotherapeutics--
CUECue Biopharma--
LYRALyra Therapeutics--
LIFEaTyr Pharma--
ANEBAnebulo Pharmaceuticals--
RZLTRezolute--
CGEMCullinan Oncology--
CCCCC4 Therapeutics--
ANTXAN2 Therapeutics--
GRCLGracell Bio--
BCABBioAtla--
TARAProtara Therapeutics--
CYTCyteir Therapeutics--
TRVITrevi Therapeutics--
NLTXNeurogene--
PRLDPrelude Therapeutics--
ORICORIC Pharmaceuticals--

TRVI Revenue FAQ

What is Trevi Therapeutics’s yearly revenue?

Trevi Therapeutics's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. TRVI's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

What is Trevi Therapeutics’s quarterly revenue?

Trevi Therapeutics's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). TRVI's quarterly revenue for Q4 2023 was $176K, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).

What is Trevi Therapeutics’s revenue growth rate?

Trevi Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.